TRSZX | VMGMX | TRSZX / VMGMX | |
Total Expense Ratio | 0.00 | 0.07 | - |
Annual Report Gross Expense Ratio | 0.25 | 0.07 | 357% |
Fund Existence | 5 years | 14 years | - |
Gain YTD | 9.444 | 15.568 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 308M | 31.5B | 1% |
Annual Yield % from dividends | 0.92 | 0.63 | 147% |
Returns for 1 year | 22.15 | 28.59 | 77% |
Returns for 3 years | 62.81 | 59.96 | 105% |
Returns for 5 years | 69.45 | 71.12 | 98% |
Returns for 10 years | N/A | 178.39 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVIX | 10.10 | 0.06 | +0.60% |
American Century Small Cap Value Inv | |||
GRLLX | 20.15 | 0.08 | +0.40% |
Goldman Sachs Enhanced U.S. Equity R | |||
HFSSX | 16.06 | 0.06 | +0.37% |
Hartford Schroders Intl Cntrrn Val SDR | |||
FBTTX | 25.58 | N/A | N/A |
Fidelity Advisor Biotechnology M | |||
NZDCHF | 0.48 | N/A | N/A |
New Zealand Dollar - Switzerland Franc |